Lopez et al., 2011 - Google Patents

Promiscuity of carbonic anhydrase II. Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors

Lopez et al., 2011

View PDF
Document ID
1906384458777772211
Author
Lopez M
Vu H
Wang C
Wolf M
Groenhof G
Innocenti A
Supuran C
Poulsen S
Publication year
Publication venue
Journal of the American Chemical Society

External Links

Snippet

Carbonic anhydrases (CAs) are enzymes whose endogenous reaction is the reversible hydration of CO2 to give HCO3–and a proton. CA are also known to exhibit weak and promiscuous esterase activity toward activated esters. Here, we report a series of findings …
Continue reading at pure.mpg.de (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology

Similar Documents

Publication Publication Date Title
Lopez et al. Promiscuity of carbonic anhydrase II. Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors
Hopkins et al. Long-time-step molecular dynamics through hydrogen mass repartitioning
Arcon et al. Molecular dynamics in mixed solvents reveals protein–ligand interactions, improves docking, and allows accurate binding free energy predictions
Klähn et al. On the mechanism of hydrolysis of phosphate monoesters dianions in solutions and proteins
Gaspari et al. Kinetic and structural insights into the mechanism of binding of sulfonamides to human carbonic anhydrase by computational and experimental studies
Fisher et al. Speeding up proton transfer in a fast enzyme: kinetic and crystallographic studies on the effect of hydrophobic amino acid substitutions in the active site of human carbonic anhydrase II
Kim et al. Contribution of fluorine to protein− ligand affinity in the binding of fluoroaromatic inhibitors to carbonic anhydrase II
Naumann et al. Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes
Pastor et al. A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure− activity relationship analysis
Fisher et al. Coulombic effects of remote subsites on the active site of ribonuclease A
Paudel et al. Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X
Klett et al. MM-ISMSA: an ultrafast and accurate scoring function for protein–protein docking
Annila et al. Solution structure of nodularin: an inhibitor of serine/threonine-specific protein phosphatases
Manzoni et al. Elucidation of hydrogen bonding patterns in ligand-free, lactose-and glycerol-bound galectin-3C by neutron crystallography to guide drug design
Wang et al. Intramolecular hydrogen-bonding in aqueous carbohydrates as a cause or consequence of conformational preferences: a molecular dynamics study of cellobiose stereoisomers
McConnell Biotin’s lessons in drug design
Barrese III et al. Inhibition of carbonic anhydrase II by thioxolone: a mechanistic and structural study
Haldar et al. A multiscale simulation approach to modeling drug–protein binding kinetics
Sohn et al. Experimental Validation of the Docking Orientation of Cdc25 with Its Cdk2− CycA Protein Substrate
McAulay et al. Reactivity of covalent fragments and their role in fragment based drug discovery
Forli et al. Lennard-Jones potential and dummy atom settings to overcome the AUTODOCK limitation in treating flexible ring systems
Mahon et al. Mapping selective inhibition of the cancer-related carbonic anhydrase IX using structure–activity relationships of glucosyl-based sulfamates
Johnson et al. On the mechanism of dimethylarginine dimethylaminohydrolase inactivation by 4-halopyridines
Vedani et al. Quasi-atomistic receptor surface models: A bridge between 3-D QSAR and receptor modeling
Gomez-Gutierrez et al. Identification of potential small molecule binding pockets in p38α MAP kinase